Sulforhodamine B Assay and Chemosensitivity

作者: Wieland Voigt

DOI: 10.1385/1-59259-869-2:039

关键词: Sulforhodamine BCell growthTrichloroacetic acidCytotoxicityFluorescenceCellular proteinChemistryBiochemistryClonogenic assaySolubilization

摘要: The sulforhodamine B (SRB) assay was developed by Skehan and colleagues to measure drug-induced cytotoxicity cell proliferation for large-scale drug-screening applications. Its principle is based on the ability of protein dye bind electrostatically pH dependent basic amino acid residues trichloroacetic acid-fixed cells. Under mild acidic conditions it binds under can be extracted from cells solubilized measurement. Results SRB were linear with number cellular measured at densities ranging 1 200% confluence. sensitivity comparable that several fluorescence assays superior Lowry or Bradford. signal-to-noise ratio favorable resolution 1000-2000 cells/well. It performed similarly compared other such as MTT clonogenic assay. possesses a colorimetric end point nondestructive indefinitely stable. These practical advances make an appropriate sensitive even application.

参考文章(10)
Berenbaum Mc, What is synergy Pharmacological Reviews. ,vol. 41, pp. 93- 141 ,(1989)
Louis Hodes, Kenneth Paull, Antonis Koutsoukos, Lawrence Rubinstein, Exploratory data analytic techniques to evaluate anticancer agents screened in a cell culture panel. Journal of Biopharmaceutical Statistics. ,vol. 2, pp. 31- 48 ,(1992) , 10.1080/10543409208835029
Raymond P. Perez, Andrew K. Godwin, Laura M. Handel, Thomas C. Hamilton, A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines European Journal of Cancer. ,vol. 29, pp. 395- 399 ,(1993) , 10.1016/0959-8049(93)90394-U
L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. Simon, S. Tosini, P. Skehan, D. A. Scudiero, A. Monks, M. R. Boyd, Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Journal of the National Cancer Institute. ,vol. 82, pp. 1113- 1118 ,(1990) , 10.1093/JNCI/82.13.1113
Yvonne P. Keepers, Paulo E. Pizao, Godefridus J. Peters, Jannette van Ark-Otte, Benjamin Winograd, Herbert M. Pinedo, Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 897- 900 ,(1991) , 10.1016/0277-5379(91)90142-Z
K.T Papazisis, G.D Geromichalos, K.A Dimitriadis, A.H Kortsaris, Optimization of the sulforhodamine B colorimetric assay Journal of Immunological Methods. ,vol. 208, pp. 151- 158 ,(1997) , 10.1016/S0022-1759(97)00137-3
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening Journal of the National Cancer Institute. ,vol. 82, pp. 1107- 1112 ,(1990) , 10.1093/JNCI/82.13.1107
Schmoll Hj, Voigt W, Müller T, Schoeber C, Bulankin A, Hoang-Vu C, Grothey A, Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines. Clinical Cancer Research. ,vol. 6, pp. 2087- 2093 ,(2000)
J C Parsons, G Bravo, W R Greco, The search for synergy: a critical review from a response surface perspective. Pharmacological Reviews. ,vol. 47, pp. 331- 385 ,(1995)